Literature DB >> 7655418

Adriamycin-Fe3+-induced mitochondrial protein damage with lipid peroxidation.

T Miura1, S Muraoka, T Ogiso.   

Abstract

Exposure of mitochondria to adriamycin (ADM)-Fe3+ induced formation of thiobarbituric acid reactive substances and fluorescent substances. Butylated hydroxytoluene (BHT) and the water soluble vitamin E analogue, trolox, not only strongly inhibited fluorescence formation but also mitochondrial lipid peroxidation. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicated the formation of high molecular weight proteins when mitochondria were exposed to ADM-Fe3+. A mitochondrial protein with a molecular weight of approximately 30 kDa was very sensitive to ADM-Fe3+. BHT and trolox strongly inhibited mitochondrial protein cross-linking, indicating that the protein modification was due to ADM-Fe(3+)-induced lipid peroxidation. In addition, the susceptibility of ADM-Fe(3+)-exposed mitochondrial protein to proteases was unchanged. Bovine serum albumin (BSA) inhibited ADM-Fe(3+)-induced mitochondrial lipid peroxidation. Fluorescence emmited from BSA was detected during ADM-Fe(3+)-induced mitochondrial lipid peroxidation, and BHT strongly inhibited the oxidative modification of BSA. These results suggest that the oxidative modification of mitochondrial proteins and BSA is due to ADM-Fe(3+)-induced lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655418     DOI: 10.1248/bpb.18.514

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

Review 1.  Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.

Authors:  Navid Koleini; Elissavet Kardami
Journal:  Oncotarget       Date:  2017-07-11

2.  Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 signaling pathways.

Authors:  Ziyun Lu; Zhiyi Liu; Bei Fang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.